Money

By Chris Hetner, Senior Executive, Board Director, and Leader in Cybersecurity, Former SEC Chair Senior Cybersecurity Advisor; Dominique Shelton Leipzig, Founder & CEO, Global Data Innovation; Steve Roycroft, CEO of RANE; Ali Plucinski, Cyber Analyst, RANE The White House has devoted particular attention to the technology space amid ongoing advancements in the burgeoning artificial intelligence (AI)…

The Australian government took significant steps to advance its resource sector in 2025. Aside from the usual project investments, grants and tax assistance, the year was also a time for making big decisions on considering new regulations, revisiting old policies and signing new agreements. Read on to look back at the Investing News Network’s most…

The last few months of 2025 haven’t brought what investors in Meta Platforms (NASDAQ: META) hoped for. Through late October, shares were up around 28% on the year. Since then, the stock has given back around half those gains, and is now up only 14% (as of the Dec. 18 close). However, investors may take…

Corn futures closed the Wednesday session with steady to fractionally lower trade to wind down 2025. The CmdtyView national average Cash Corn price was down another 1 ½ cents at $3.96 1/4. The market will be closed on Thursday for New Years Day, with a hard open at 8:30 am CST on Friday.  Commitment of Traders…

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Therapeutics Corp (Symbol: UTHR), where a total of 11,954 contracts have traded so far, representing approximately 1.2 million underlying shares. That amounts to about 257.9% of UTHR’s average daily trading volume over the past month of 463,450…

Key Points Real estate investment trusts (REITs) can be powerful wealth builders in your portfolio. REITs often outperform stocks, partly due to their dividends. REITs tend to offer dividend yields that are well above average. 10 stocks we like better than Realty Income › Most of us should at least be considering holding some real…

Most of the health care sector’s headlines are dominated by Big Pharma giants. Legacy companies, including AbbVie (NYSE: ABBV), Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE), and Merck (NYSE: MRK)—and their lineup of game-changing drugs—receive the lion’s share of attention. But one newcomer is making a splash, and investors looking for growth opportunities in the…

In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Oruka Therapeutics, up about 5.5% and shares of Arcutis Biotherapeutics, up about 5% on the day. And underperforming other ETFs today is the Sprott Silver Miners…

Despite disappointing performance throughout most of 2025, shares of Rivian Automotive (NASDAQ: RIVN) are finishing the year strong. Through the Nov. 4 close, the automaker was down 6% in 2025. However, the stock has soared by 57% since then, bringing its year-to-date return to 47% through the Dec. 30 close. This comes as a series…

If analysts are correct, lower interest rates today will bring an unwelcome spike in inflation in 2026. While it may not be anything like the 7% to 8% inflation rate of 2022 and 2023, the consensus view is that inflation will remain above the Federal Reserve’s preferred 2% target for some time to come. That…